Mild cognitive impairment: A ‘hardening of the categories’?

Dementia

Volumn 5, Issue 1, 2006, Pages 11-25

  Whitehouse, Peter J ^a   Moody, Harry R ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b AARP   (United States)

Author keywords

aging; Alzheimer's disease; drug development; ethics; philosophy

Indexed keywords

EID: 84993682718     PISSN: 14713012     EISSN: None     Source Type: Journal    
DOI: 10.1177/1471301206059752     Document Type: Article

References (34)

1. Auchus, A., & Chen, C. (2001). Asia regional meeting of the International Working Group for theHarmonization of Dementia Drug Guidelines: Meeting report. Alzheimer Disease & Associated Disorders, 15(2), 66–68.
2. Auchus, A., Chen, C., Orgogozo, J.-M., Sawada, T., Senanarong, V., & Whitehouse, P. (2003). 2nd Asia Pacific Regional Meeting of the International Working Group onHarmonization of Dementia Drub Guidelines: Meetings report. Alzheimer Disease & Associated Disorders, 17(2), 129–131.
3. Ballenger, J., & Whitehouse, P. (1998). The body as cultural text. Review of Nerves and narratives: A culturalhistory of hysteria in nineteenth-century British prose. Medical Humanities Review, 12(1), 96–99.
4. Bamford, C., Lamont, S., Eccles, M., Robinson, L., May, C., & Bond, J. (2004). Disclosing a diagnosis of dementia: A systematic review. International Journal of Geriatric Psychiatry, 19(2), 151–169.
5. Bewes, T. (2002). Reification: Or the anxiety of late capitalism. London and New York: Verso.
6. Corner, L., & Bond, J. (in press). The impact of the label of Mild Cognitive Impairment on theindividual's sense of self. Psychiatry and Psychology Journal.
7. Crook, T., Bartus, R., Ferris, S., Whitehouse, P., Cohen, G., & Gershon, S. (1986). Age-associated memory impairment: Proposed diagnostic criteria and measuresof clinical change – Report of a National Institute of MentalHealth Work Group. Developmental Neuropsychology, 2, 261–276.
8. Dubois, B. (2000). ‘Prodromal Alzheimer's disease’: A more usefulconcept than mild cognitive impairment? Current Opinion in Neurology, 13, 367–369.
9. Fahy, M., Wald, C., Walker, Z., & Livingston, G. (2003). Secrets and lies: The dilemma of disclosing the diagnosis to an adult with dementia. Age and Ageing, 32(4), 439–441.
10. Gauthier, S. (2004). Pharmacotherapy of mild cognitive impairment. Dialogues in Clinical Neuroscience, 6(4), 391–395.
11. Graham, J., Rockwood, K., & Beattie, B. (1997). Prevalence and severity of cognitive impairment with and without dementiain an elderly population. The Lancet, 349, 1793–1796.
12. Gubrium, J. (2000). Narrative practice and the inner worlds ofAlzheimer disease experience. In P. Whitehouse, K. Maurer, & J. Ballenger (Eds.), Concepts of Alzheimer disease: Biological, clinical, andcultural perspectives(pp. 181–203). Baltimore, MD: Johns Hopkins Press.
13. Kral, V. (1962). Senescent forgetfulness: Benign and malignant. Canadian Medical Association Journal, 86, 257–260.
14. Levy, R., on behalf of the Aging-Associated Cognitive Decline Working Party(1994). Aging-associated cognitive decline. Report of the Working Party of theInternational Psychogeriatric Association. International Psychogeriatrics, 6, 63–68.
15. Maslow, K., & Whitehouse, P.J. (2003). Bridging Research and Care Symposia Panel ‘Mild cognitiveimpairment: Should we be diagnosing it? What can we offer people who have it?’Paper presented at the 11th National Alzheimer's DiseaseEducation Conference, 20–23 July, Chicago, IL.
16. Mittelman, M. (2003). Depression, anxiety, denial and sense of mastery in persons with mildcognitive impairment. The Gerontologist, 43(Special Issue I),148–148. (In: Program Abstracts 56th Annual Scientific Meeting: Our FutureSelves: Research, Education and Services for Early Development and Childhood in anAging Society.)
17. Moody, H. (1992). Ethics in an aging society. Baltimore, MD: Johns Hopkins University Press.
18. Moody, H. (1998). The cost of autonomy, the price ofpaternalism. In R. Dobrof, R. Dische, & H.R. Moody (Eds.), The cost of autonomy, the price of paternalism. New York: Haworth Press.
19. Moody, H. (2004). Ethical dilemmas in old age care. In M. Johnson (Ed.), Cambridge handbook of age and ageing. Cambridge: Cambridge University Press.
20. Petersen, R. (2003). Mild cognitive impairment: Aging toAlzheimer's disease. Oxford: Oxford University Press.
21. Post, S. (2003). The concept of Alzheimer disease in ahypercognitive society. In P. Whitehouse, K. Maurer, & J. Ballenger (Eds.), Concepts of Alzheimer disease: Biological, clinical, andcultural perspectives(pp. 245–256). Baltimore, MD: John Hopkins University Press.
22. Post, S., Ripich, D., & Whitehouse, P. (1994). Discourse ethics: Research, dementia and communication. Alzheimer Disease and Associated Disorders, 8(4), 58–65.
23. Powell, J.L., & Moody, H.R. (2003). The challenge of modernity: Habermas and critical theory. Theory and Science, 4(1) Retrieved 15September 2005 from theoryandscience.icaap.org/volume4issue1.html.
24. Ritchie, K., Artero, S., & Touchon, J. (2001). Classification criteria for mild cognitive impairment: A population-basedvalidation study. Neurology, 56, 37–42.
25. Ritchie, K., & Lovestone, S. (2002). The dementias. Lancet, 360, 1759–1766.
26. Sano, M., Ernesto, C., & Thomas, R. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatmentfor Alzheimer's disease. New England Journal of Medicine, 336, 1216–1222.
27. Taussig, M. (1991). Reification and the consciousness of the patient: Thenervous system (pp. 83–109). New York: Routledge.
28. Whitehouse, P. (2002). Review of Losing my mind: An intimate look at life withAlzheimer'sby Thomas DeBaggio. New England Journal of Medicine, 347(11), 861-861.
29. Whitehouse, P. (2003a). Letter to Lancet‘Classificationsof the dementias’, commentary on ‘The Dementias’article by Richies and Lovestone Lancet2002,360,1759–66. The Lancet, 361, 1227.
30. Whitehouse, P. (2003b). Special article: Guidelines abstracted from the American Academy ofNeurology's Dementia Guidelines for Early Detection, Diagnosis, andManagement of Dementia. Journal of the American Geriatric Society, 51, 869–873.
31. Whitehouse, P. (2004a). Mild cognitive impairment: The beginnings of theend of AD. Psychiatric Time: 87–88.
32. Whitehouse, P. (2004b). Regulatory aspects of MCI. Dialogues in Clinical Neuroscience, 6(4), 409–414.
33. Whitehouse, P., Maurer, K., & Ballenger, J. (2000). Concepts of Alzheimer disease: Biological, clinical,and cultural perspectives. Baltimore, MD: Johns Hopkins University Press.
34. Whitehouse, P., Frisoni, G.B., & Post, S. (2004). Breaking the diagnosis of dementia. The Lancet Neurology, 3, 124–128.